BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8604281)

  • 1. Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Pediatrics; 1996 Mar; 97(3):404-12. PubMed ID: 8604281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cluster of meningococcal diseases in Allgaeu -- strategies for intervention].
    Hautmann W; Harms I; Vogel U; Zirngibl A; Wildner M
    Gesundheitswesen; 2005 Dec; 67(12):853-7. PubMed ID: 16379047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2005 Aug; 116(2):496-505. PubMed ID: 15995007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American academy of Pediatrics addresses meningococcal disease prevention and control strategies.
    Am Fam Physician; 1996 Jul; 54(1):362-4. PubMed ID: 8677843
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent trends in meningococcal epidemiology and current vaccine recommendations.
    Baltimore RS
    Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers.
    Can Commun Dis Rep; 1999 Sep; 25():1-12. PubMed ID: 10765571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of meningococcal disease.
    Kimmel SR
    Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive meningococcal disease--management and treatment].
    Garlicki A; Bociqga-Jasik M; Kalinowska-Nowak A
    Przegl Epidemiol; 2008; 62 Suppl 1():39-44. PubMed ID: 22320034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease--New England, 1993-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(29):629-33. PubMed ID: 10458536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council.
    Patel MS; Collignon PJ; Watson CR; Condon RJ; Doherty RR; Merianos A; Stewart GJ
    Med J Aust; 1997 Jun; 166(11):598-601. PubMed ID: 9201182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group.
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R189-95. PubMed ID: 8556102
    [No Abstract]   [Full Text] [Related]  

  • 17. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents.
    Brigham KS; Sandora TJ
    Curr Opin Pediatr; 2009 Aug; 21(4):437-43. PubMed ID: 19421058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):13-21. PubMed ID: 9048847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings.
    Hastings L; Stuart J; Andrews N; Begg N
    Commun Dis Rep CDR Rev; 1997 Dec; 7(13):R195-200. PubMed ID: 9447784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.